The Global Fund Board has appointed Dr Nafsiah Mboi, Minister of Health in Indonesia, as the next Chair of the Board. It has also appointed Mireille Guigaz as the next Vice-Chair. Ms Guigaz currently represents France on the Board. Dr Mboi does not currently sit on the Board. Both appointments are effective at the end of the 29th Board meeting in June 2013; the two terms will run until the end of the first Board meeting in 2015.
You are here
Global Fund Board
The Global Fund Board has approved Phase 2 funding for a Round 9 HIV grant in Bosnia and Hercegovina in the amount of $13.5 million. The principal recipient (PR) for the grant is the United Nations Development Programme (UNDP). UNDP is also PR for another HIV grant, which has been essentially completed, and for a TB grant in Bosnia and Hercegovina.
The Global Fund Board has approved Phase 2 funding for a Round 2 malaria rolling continuation channel grant in Namibia. The principal recipient (PR) for this grant is the National Malaria Control Programme (NMCP) in the Ministry of Health and Social Services. In approving the Phase 2 funding, the Board was acting on recommendations from the Grants Renewal Panel in the Secretariat.
The Global Fund Board has approved Phase 2 funding for two Round 9 HIV grants in Pakistan. Funding of $7.1 million was approved for one of the grants, for which the principal recipient (PR) is the National AIDS Control Programme. Funding of $11.3 million was approved for the other grant, for which the PR is the Nai Zindagi Trust.
In an email sent to Board members on 7 March, Global Fund Executive Director Mark Dybul explained how indicative allocations for early and interim applicants could be adjusted to account for qualitative factors and other variables.
In an email sent to Board members on 7 March, Global Fund Executive Director Mark Dybul provided additional information on the transition phase of the new funding model (NFM). The email was in response to questions posed to the Secretariat since the NFM was launched on 28 February.
The Developed Country NGO delegation on the Global Fund Board has issued a call for nominations for the position of Board member. The position has a two-year term: July 2013–June 2015. The deadline for applications is 8 April 2013.
The Global Fund Board has decided that the Affordable Medicines Facility-malaria (AMFm) programme will not continue as a stand-alone programme, but elements will be retained and integrated into the core funding system. The decision was made at the 28th Global Fund Board meeting held in Geneva on 14th and 15th of November.
Implementation of the new funding model approved by the Global Fund Board (see article 4) will roll out in 2013 with a test of the full implementation in about five countries. The lessons from countries that participate in this phase will be absorbed into the NFM as it gains momentum for full implementation for all eligible countries in 2014.
The Global Fund Board has approved a design for the new funding model, though some elements of the design will require further work. The Board has also approved a transition phase for 2013 as a way of testing various elements of the new model. The full model will not likely be rolled out until 2014.